Company Overview and News

 
NFX or CLR: Which Is the Better Value Stock Right Now?

2018-10-19 zacks
Investors interested in stocks from the Oil and Gas - Exploration and Production - United States sector have probably already heard of Newfield Exploration (NFX - Free Report) and Continental Resources (CLR - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.
CTLR CLR NFX

4
Oil Boom Drives North Dakota Production to Record Levels

2018-10-19 zacks
As per North Dakota’s oil regulator, the state’s daily crude output rose 1.7% in August after increasing 3.4% in the previous month. The North Dakota Department of Mineral Resources’ (‘DMR’) latest data said that oil production in August averaged a record 1,291,496 barrels a day, up 22,206 barrels a day from July.
ENBBF WLL PSX CTLR MALRY ENB ISRG MPC MIN NSC ENB ETP OAS FFIV EBBNF CLR MALRF

9
7 Energy Stocks to Sell Immediately

2018-10-19 investorplace
Volatility has returned to U.S. equity markets, with the Dow Jones Industrial Average falling as much as 300 points before recovering back to the unchanged line in mid-day trading on Wednesday. Investors were spooked by soft housing data showing that buyers are stepping back — despite an extremely strong labor market — as interest rates rise.
APA HES NOV PSX CTLR COP DO CLR MS

2
The Bakken Is Back

2018-10-16 seekingalpha
The Bakken production reaches a new high, indicating the failure of earlier pronouncement of its demise.
OAS WLL CTLR CLR

 
California Resources Finds A New Catalyst For Growth

2018-10-15 seekingalpha
California Resources is seeing a boost in production from a new acquisition and is consequently raising production targets.
CRC CTLR CLR

12
Consider Buying Chevron As Oil Prices Climb

2018-10-11 seekingalpha
The company has also become a major player in the global LNG market, where supply contracts are pegged to oil prices.
WOPEF RDS.B RDS.A XOM CTLR RDSB RDSA WPL WOPEY COP BP CVX RYDBF TRI CLR RYDAF

13
7 Oil Stocks to Buy as the Energy Market Heats Up

2018-10-09 investorplace
Is the bromance between President Donald Trump and Russian leader Vladimir Putin losing its passion? It seemed that way when Putin recently shared his thoughts about rising oil prices and oil stocks in general. The Russian strongman agreed with Trump that prices have skyrocketed. However, Putin placed blame on his administration for much of the pain.
CVX CTLR MRO EPD CLR OXY BXE EOG

4
Run The U.S. Oil Marathon With Marathon Oil

2018-10-08 seekingalpha
Marathon Oil has built an attractive oil and gas production portfolio in four major U.S. basins: Bakken, Eagle Ford, STACK/SCOOP, and Permian. It also has some overseas operations.
STT MQBKY BOE WPXP WLL SM CTLR MCQEF AXAS MPC WPX EV EOG OAS WTI MRO CLR MQG

57
E&P 'Middle Of The Road Club' (Permian Edition) #18-1

2018-10-08 seekingalpha - 5
E&P companies that are neither top institutional favorites nor companies I would classify in my Bottom of the Barrel Club may have wide appeal to investors.
GIS XOM PXD QEP AR CRZO WMB XOG NBL WLL PDCE SRCI SM CTLR NFX RRS WPX ESTE RGRLF RRC WTI CLR OXY AEUA HAL APC APA WPXP DVN CXO PE RRL COP ROSEU RSPP REI AMR EGN JAG ROSE CDEV D COG EOG RGRYY HP CVX LPI HK FANG

29
E&P 'Middle Of The Road Club' (Non-Permian Edition) #18-1

2018-10-01 seekingalpha - 2
E&P companies that are neither top institutional favorites nor companies I would classify in my Bottom of the Barrel Club may have wide appeal to investors.
APC APA WPXP DVN QEP PE CXO EPE RRL AR CRZO ROSEU REI GPOR JNEEP AMR MUR.WI MUR JAG ROSE XOG JGPK NBL WLL PDCE SRCI SM CTLR COG BCEI NFX RRS JONE WPX RGRLF EOG RRC OAS RGRYY LPI MRO CLR ROAN AEUA FANG

 
Baird Says Large-Cap Energy Stocks Are Cheap: 4 to Buy Now

2018-10-01 247wallst
Despite the sharp rise in oil prices, some of the top stocks have continued to trade at less than their net asset value using current NYMEX price. With supply becoming stretched as a result of the sanctions placed on Iran and the continuing issues in Venezuela, there is a good chance the price of West Texas Intermediate can stay over the $70 a barrel level the rest of 2018. While that is tough for consumers, it is huge for some of the top exploration and production companies.
XEC CTLR CLR

1
Sanchez Energy Update: Production Woes Continue

2018-09-28 seekingalpha - 1
Due to two quarters in a row of production issues, and Comanche still not being a proven asset, SN is in a wait and see mode before investors can double down on shares.
SN CTLR SCAZP CLR SNZYP

 
Move Over, Permian. Bakken's Making a Comeback.

2018-09-26 rigzone
After months of being the red-headed stepchild to the Permian, the Bakken shale play is getting a resurgence.
CTLR CLR

7
FAANG Valuations In The Shale Patch: The Fracking Darlings Are Still Expensive

2018-09-25 seekingalpha - 1
At current oil prices ($70 WTI), the fracking industry in aggregate is slightly above its cash flow breakeven, and barely profitable.
OAS WPXP WLL CTLR DVN CXO PE CLR WPX FANG

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to CLR / Continental Resources, Inc. on message board site Silicon Investor.

ClearONE Communications (CLRO) ClearONE Communications (CLRO) ClearONE Communications (CLRO) CLRA Claria - formerly Gator Corp. CLRA Claria - formerly Gator Corp. CLRA Claria - formerly Gator Corp.
Ocular Sciences (OCLR) Ocular Sciences (OCLR) Ocular Sciences (OCLR) CLRT u003cnasdqu003e CLRT u003cnasdqu003e CLRT u003cnasdqu003e
CLRS Company Status/Future CLRS Company Status/Future CLRS Company Status/Future Clarent Corporation (CLRN) Clarent Corporation (CLRN) Clarent Corporation (CLRN)
CLRT: Celerity Systems, Inc. CLRT: Celerity Systems, Inc. CLRT: Celerity Systems, Inc. CLRT -- Celerity Systems, Inc CLRT -- Celerity Systems, Inc CLRT -- Celerity Systems, Inc
ICON plc (ICLR) drop 50% in Value is this justified!!!!!!! ICON plc (ICLR) drop 50% in Value is this justified!!!!!!! ICON plc (ICLR) drop 50% in Value is this justified!!!!!!! ACLR -ACCENT COLOR SCIENCE???? ACLR -ACCENT COLOR SCIENCE???? ACLR -ACCENT COLOR SCIENCE????
CUSIP: 212015101